Literature DB >> 30835523

Comparison of Positive Oral Contrast Agents for Abdominopelvic CT.

Sebastian Winklhofer1,2, Wei-Ching Lin1,3,4, Zhen Jane Wang1, Spencer C Behr1, Antonio C Westphalen1, Benjamin M Yeh1.   

Abstract

OBJECTIVE: The objective of our study was to compare the quality of bowel opacification from three different positive oral contrast agents-barium sulfate, diatrizoate, and iohexol-at abdominopelvic CT.
MATERIALS AND METHODS: Abdominopelvic CT examinations with three different oral contrast agents (each contrast agent: n = 300 patients) of 900 patients were retrospectively evaluated by two independent readers. For four segments of the gastrointestinal tract (i.e., the stomach, jejunum, ileum, and colon), readers recorded qualitative data (grade of nonuniform lumen opacification, types of inhomogeneous opacifications, presence of artifacts, and distribution of contrast agent) and quantitative data (CT attenuation of lumen [in Hounsfield units]). The results were compared among the three contrast agents using the Mann-Whitney U test and repeated-measures ANOVA with a post hoc Bonferroni correction.
RESULTS: Fewer artifacts were detected with iohexol (4.3%) as the oral contrast agent than with diatrizoate (13.0%) and barium sulfate (14.3%) (each, p < 0.05). Barium showed a greater frequency of bowel lumen heterogeneity (388/831 segments, 47%) than iohexol (155/679, 23%) and diatrizoate (185/763, 24% segments) (p < 0.001). Barium showed higher CT attenuation than iohexol and diatrizoate in the stomach but lower CT attenuation in the ileum (each, p < 0.05).
CONCLUSION: The frequency of inhomogeneous bowel opacification was lower for iohexol than for diatrizoate or barium sulfate. Barium showed the highest frequency of bowel lumen heterogeneity. The iodinated agents showed greater increases in mean CT attenuation from the proximal bowel segments to the distal bowel segments than barium sulfate.

Entities:  

Keywords:  CT; barium; image quality; iodine; oral contrast agents

Year:  2019        PMID: 30835523     DOI: 10.2214/AJR.18.20445

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  3 in total

1.  Comparison of Mannitol, Water, and Iodine-Based Oral Contrast in the Evaluation of the Bowel by Multi-Detector Computed Tomography.

Authors:  Sai Soumya Thati; Rachegowda Nagegowda; Anil K Sakalecha; Shivaprasad G Savagave; Divya T Patil
Journal:  Cureus       Date:  2022-04-20

2.  Dextran-Coated Cerium Oxide Nanoparticles: A Computed Tomography Contrast Agent for Imaging the Gastrointestinal Tract and Inflammatory Bowel Disease.

Authors:  Pratap C Naha; Jessica C Hsu; Johoon Kim; Shrey Shah; Mathilde Bouché; Salim Si-Mohamed; Derick N Rosario-Berrios; Philippe Douek; Maryam Hajfathalian; Parisa Yasini; Sanjay Singh; Mark A Rosen; Matthew A Morgan; David P Cormode
Journal:  ACS Nano       Date:  2020-07-28       Impact factor: 15.881

Review 3.  Recent Progress in the Diagnosis and Precise Nanocarrier-Mediated Therapy of Inflammatory Bowel Disease.

Authors:  Liucan Wang; Min Yu; Hua Yang
Journal:  J Inflamm Res       Date:  2021-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.